M. Mousli

发表

TIP60 governs the auto-ubiquitination of UHRF1 through USP7 dissociation from the UHRF1/USP7 complex

Y. Mély, C. Bronner, A. Hamiche, 2020, International journal of oncology.

A molecular tool targeting the base flipping activity of human UHRF1.

M. Botta, C. Boudier, Y. Mély, 2019, Chemistry.

ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression.

C. Bronner, Y. Lutz, M. Mousli, 2000, Cancer research.

ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells

D. Monté, C. Bronner, A. Abbady, 2003, British Journal of Cancer.

Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy

C. Bronner, M. Alhosin, Wei Wu, 2017, Oncology letters.

Toxoplasma gondii exploits UHRF1 and induces host cell cycle arrest at G2 to enable its proliferation

Yusuke Nakamura, M. Unoki, M. Mousli, 2008, Cellular microbiology.

Regulation of Toxoplasma gondii multiplication in BeWo trophoblast cells: cross-regulation of nitric oxide production and polyamine biosynthesis.

M. Mousli, J. Klein, E. Candolfi, 2005, International journal for parasitology.

Thymoquinone challenges UHRF1 to commit auto-ubiquitination: a key event for apoptosis induction in cancer cells

Y. Mély, C. Bronner, M. Alhosin, 2018, Oncotarget.

Interaction of the epigenetic integrator UHRF1 with the MYST domain of TIP60 inside the cell

Y. Mély, C. Bronner, M. Alhosin, 2017, Journal of experimental & clinical cancer research : CR.

Luteolin Induces Apoptosis in BE Colorectal Cancer Cells by Downregulating Calpain, UHRF1, and DNMT1 Expressions

M. Mousli, L. Chekir‐Ghedira, K. Ghédira, 2014, Nutrition and cancer.

Cytokine profiles in toxoplasmic and viral uveitis.

M. Mousli, J. Garweg, T. Abdelrahman, 2009, The Journal of infectious diseases.

Bradykinin-induced contraction of guinea pig lung in vitro

J. Gies, M. Mousli, A. Trifilieff, 1994, Naunyn-Schmiedeberg's Archives of Pharmacology.

Impact of foetus and mother on IFN-gamma-induced indoleamine 2,3-dioxygenase and inducible nitric oxide synthase expression in murine placenta following Toxoplasma gondii infection.

M. Mousli, O. Takikawa, J. Klein, 2008, International journal for parasitology.

Co-solubilization of bradykinin B2 receptors and angiotensin-converting enzyme from guinea pig lung membranes.

J. Gies, M. Mousli, A. Trifilieff, 1994, Biochimica et biophysica acta.

CD 47 Activation-induced UHRF 1 Over-expression Is Associated with Silencing of Tumor Suppressor Gene p 16 INK 4 A in Glioblastoma Cells

Y. Mély, C. Bronner, M. Alhosin, 2014 .

CD47 activation-induced UHRF1 over-expression is associated with silencing of tumor suppressor gene p16INK4A in glioblastoma cells.

Y. Mély, C. Bronner, M. Alhosin, 2015, Anticancer research.

M2-muscarinic receptors: how does ligand binding affinity relate to intrinsic activity?

J. Gies, M. Mousli, L. Daeffler, 1996, Journal of receptor and signal transduction research.

1,25-Dihydroxyvitamin D3 induces splenocyte apoptosis and enhances BALB/c mice sensitivity to toxoplasmosis

C. Bronner, M. Mousli, V. Letscher-Bru, 2005, The Journal of Steroid Biochemistry and Molecular Biology.

Epigallocatechin-3-gallate up-regulates tumor suppressor gene expression via a reactive oxygen species-dependent down-regulation of UHRF1.

C. Bronner, M. Alhosin, V. Schini-Kerth, 2012, Biochemical and biophysical research communications.

A Concern Regarding the Current Confusion with the Human Homolog of Mouse Np95, ICBP90/UHRF1

C. Bronner, M. Unoki, M. Mousli, 2008, Radiation research.

Limoniastrum guyonianum aqueous gall extract induces apoptosis in human cervical cancer cells involving p16INK4A re-expression related to UHRF1 and DNMT1 down-regulation

Y. Mély, C. Bronner, M. Alhosin, 2013, Journal of experimental & clinical cancer research : CR.

UHRF1 recruits the histone acetyltransferase Tip60 and controls its expression and activity.

C. Bronner, M. Alhosin, V. Schini-Kerth, 2009, Biochemical and biophysical research communications.

Isoleucine 10 is essential for DNA gyrase B function in Escherichia coli.

C. Bronner, M. Mousli, L. Brino, 1999, Biochimie.

Toxoplasma gondii-induced foetal resorption in mice involves interferon-gamma-induced apoptosis and spiral artery dilation at the maternofoetal interface.

M. Mousli, A. Neuville, J. Klein, 2009, International journal for parasitology.

Overexpression of ICBP90, a novel CCAAT-binding protein, overcomes cell contact inhibition by forcing topoisomerase II alpha expression.

C. Bronner, M. Mousli, P. Oudet, 2002, Anticancer research.

Catestatin, an endogenous Chromogranin A-derived peptide, inhibits in vitro growth of Plasmodium falciparum

B. Dunn, K. Helle, F. Delalande, 2009, Cellular and Molecular Life Sciences.

Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties

T. Sharif, C. Bronner, M. Alhosin, 2011, Journal of experimental & clinical cancer research : CR.

Coordinated Dialogue between UHRF1 and DNMT1 to Ensure Faithful Inheritance of Methylated DNA Patterns

C. Bronner, M. Alhosin, A. Hamiche, 2019, Genes.

Down‐regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1‐dependent DNA‐damage checkpoint signals contributes to cell cycle arrest at G1/S transition

H. Saya, T. Fujiwara, C. Bronner, 2004, Genes to cells : devoted to molecular & cellular mechanisms.

Interaction of substance P, compound 4880 and mastoparan with the α-subunit C-terminus of G protein

J. Bockaert, C. Bronner, M. Mousli, 1990 .

Increasing role of UHRF1 in the reading and inheritance of the epigenetic code as well as in tumorogenesis.

C. Bronner, M. Mousli, M. Krifa, 2013, Biochemical pharmacology.

Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer

C. Bronner, M. Alhosin, M. Zamzami, 2016, Journal of experimental & clinical cancer research : CR.

The epigenetic integrator UHRF1: on the road to become a universal biomarker for cancer

Y. Mély, C. Bronner, M. Alhosin, 2017, Oncotarget.

Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer

C. Bronner, M. Alhosin, M. Zamzami, 2016, Journal of Experimental & Clinical Cancer Research.

S-Protected thiolated nanostructured lipid carriers exhibiting improved mucoadhesive properties.

A. Bernkop‐Schnürch, M. Mousli, Imran Nazir, 2020, International journal of pharmaceutics.

Genomic structure and chromosomal mapping of the gene coding for ICBP90, a protein involved in the regulation of the topoisomerase IIα gene expression

R. Redon, S. Manoir, C. Bronner, 2001 .

The retinoblastoma gene and its product are targeted by ICBP90: a key mechanism in the G1/S transition during the cell cycle

Christian D Muller, C. Bronner, A. Abbady, 2005, Oncogene.

Toxoplasma gondii regulates ICAM‐1 mediated monocyte adhesion to trophoblasts

M. Mousli, V. Letscher-Bru, J. Klein, 2005, Immunology and cell biology.

Expression in Escherichia coli of Y5-mutant and N-terminal domain-deleted DNA gyrase B proteins affects strongly plasmid maintenance.

E. Weiss, M. Mousli, L. Brino, 1997, Plasmid.

Dimerization of Escherichia coli DNA-gyrase B Provides a Structural Mechanism for Activating the ATPase Catalytic Center*

D. Moras, C. Bronner, A. Urzhumtsev, 2000, The Journal of Biological Chemistry.

Phosphorylation of ICBP90 by protein kinase A enhances topoisomerase IIalpha expression.

C. Bronner, A. Abbady, C. Muller, 2004, Biochemical and biophysical research communications.

Interaction of the epigenetic integrator UHRF1 with the MYST domain of TIP60 inside the cell

Y. Mély, C. Bronner, M. Alhosin, 2017, Journal of experimental & clinical cancer research : CR.

The Antiapoptotic Protein ICBP90 Is a Target for Protein Kinase 2

C. Bronner, M. Mousli, O. Filhol, 2004, Annals of the New York Academy of Sciences.

Drug discovery targeting epigenetic codes: the great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis.

M. Unoki, M. Mousli, J. Brunet, 2009, Biochemical pharmacology.

Transcriptional regulation of the human topoisomerase IIalpha gene.

C. Bronner, M. Mousli, R. Hopfner, 2002, Anticancer research.

TCR pathway involves ICBP90 gene down-regulation via E2F binding sites.

C. Bronner, A. Abbady, C. Muller, 2005, Biochemical pharmacology.

Dynamics of Methylated Cytosine Flipping by UHRF1.

Benoît Y. Michel, V. Yashchuk, C. Boudier, 2017, Journal of the American Chemical Society.

Murine neonatal infection provides an efficient model for congenital ocular toxoplasmosis.

M. Mousli, T. Abdelrahman, E. Candolfi, 2010, Experimental parasitology.

Inhibitors of UHRF1 base flipping activity showing cytotoxicity against cancer cells.

Y. Mély, M. Mori, M. Mousli, 2023, Bioorganic chemistry.

Cellular and molecular physiopathology of congenital toxoplasmosis: The dual role of IFN-γ

M. Mousli, V. Letscher-Bru, E. Candolfi, 2007, Parasitology.

Receptor-independent activation of mast cells by bradykinin and related peptides

J. Gies, M. Mousli, Y. Landry, 1993, Trends in Neurosciences.

Limoniastrum guyonianum aqueous gall extract induces apoptosis in colorectal cancer cells by inhibiting calpain activity

M. Mousli, A. Pizzi, K. Ghédira, 2014, Tumor Biology.

ICBP90 Expression Is Downregulated in Apoptosis‐Induced Jurkat Cells

C. Bronner, A. Abbady, C. Muller, 2003, Annals of the New York Academy of Sciences.

Cellular and molecular physiopathology of congenital toxoplasmosis: the dual role of IFN-gamma.

M. Mousli, V. Letscher-Bru, E. Candolfi, 2007, Parasitology.

GAIP, a protein that specifically interacts with the trimeric G protein G alpha i3, is a member of a protein family with a highly conserved core domain.

M. Farquhar, M. Mousli, M. Mousli, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Structural requirements for neuropeptide Y in mast cell and G protein activation.

J. Gies, M. Mousli, J. Pelton, 1995, European journal of pharmacology.

Natural and Synthetic Anticancer Epidrugs Targeting the Epigenetic Integrator UHRF1

Y. Mély, C. Bronner, A. Hamiche, 2023, Molecules.

Tannin extract from maritime pine bark exhibits anticancer properties by targeting the epigenetic UHRF1/DNMT1 tandem leading to the re-expression of TP73.

Y. Mély, C. Bronner, A. Hamiche, 2021, Food & function.

Peptidergic pathway in human skin and rat peritoneal mast cell activation.

C. Bronner, M. Mousli, T. Hugli, 1994, Immunopharmacology.

Human and rat cutaneous mast cells: involvement of a G protein in the response to peptidergic stimuli.

C. Bronner, M. Mousli, Y. Landry, 1995, European journal of pharmacology.

Dynamics of Methylated Cytosine Flipping by UHRF1.

Benoît Y. Michel, V. Yashchuk, C. Boudier, 2017, Journal of the American Chemical Society.